Agenus Reports Landmark 3-Year OS Data for BOT+BAL in Refractory MSS mCRC at ESMO GI
Prostate Cancer: New ESTRO Recommendations for Precision Radiotherapy
Monica Bertagnolli: Don't Abolish the NIH, Fix It
Felicia Marie Knaul: WHO to Present First Global Estimates of 5-Year Breast Cancer Survival
ESTRO Sets Practical Guidance for Focal Boosting in Prostate Cancer Radiotherapy 2026
Can SABR Replace Surgery in Selected Low-Risk Breast Cancer?
Daraxonrasib for Pancreatic Cancer: What’s Next?
BOT/BAL Shows 33% 3-Year OS in Refractory MSS mCRC Without Active Liver Metastases
Lung cancer highlights from the ESMO Congress 2024 by SPCC will take place at November 5th, 2024. It is a live webinar by SPCC which will be futuring Aleksandra Filipovic, Alfredo Addeo, Christian Rolfo. The landscape of treatment for thoracic malignancies has undergone significant and rapid advancements in recent years. New therapies, including targeted treatments, […]
Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27, 2024. It is a live webinar by SPCC and the event […]
Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at […]
Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC will be held at December 18, 2024. This live webinar serves as a crucial platform for oncologists to stay informed about […]
Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC will be held at December 19, 2024. This live webinar will start with an introduction by Nadia […]
The Cancer Summit, organized by the China Anti-Cancer Association (CACA), OncoDaily, Sharing Progress in Cancer Care (SPCC), and the World Association for Integrative Oncology (WAIO), will take place on January […]
Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be held at January 29th, 2025 at 6 pm. The Outlook for the HR+/HER2- MBC Treatment Landscape in 2025 and Beyond Live Webinar will focus on the latest advancements and future directions in treating HR+ HER2- metastatic breast cancer (MBC). Experts will […]
People, places, and platforms that support a cancer patient’s journey by SPCC will be held at March 5, 2025, Virtually. This conference focuses on the various people, places, and platforms that support a cancer patient’s journey. It highlights the importance of a comprehensive support network that goes beyond medical treatment. Compassionate healthcare professionals, supportive family […]
Basic skills in "Strategic Leading and Management in the Cancer Care Continuum" by SPCC will be held from March 7-8, 2025 at Milan, Italy. The leadership and management skills in the Cancer Care Continuum are becoming increasingly important for medical and clinical staff, as they must be prepared to address the challenges, dynamics, and complexity […]
Improving care of Early Breast Cancer (EBC) patients in Europe Investigators Meeting by SPCC will be held at Vienna, Austria at 12 March 2025. This activity, supported by Eli Lilly […]
Breaking barriers: ensuring equal cancer care access for diverse communities by SPCC will be held at March 17, 2025, Virtually. This event focuses on addressing health disparities in cancer care […]
